Adicet Bio, Inc (ACET)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Chen Schor |
| Employees: | 90 |
| Web site: | adicetbio.com |
|
200 BERKELEY STREET, 19TH FLOOR, BOSTON, MA, 02116
617-482-2333
| |
-
Formally known as:
- ADICET BIO ORD SHS
- resTORbio Inc.
| Date | Ratio |
|---|---|
| 2020-09-16 | 1:7 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Adicet Bio, Inc. discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. Lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma.
Please log in first to see chart